Detalhe da pesquisa
1.
Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice.
PLoS Pathog
; 17(6): e1009673, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34170962
2.
Vaccine protection against Zika virus from Brazil.
Nature
; 536(7617): 474-8, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27355570
3.
Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial.
J Infect Dis
; 223(10): 1707-1716, 2021 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966573
4.
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.
Lancet
; 391(10120): 563-571, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217375
5.
Production and testing of dengue virus strains suitable for human infection studies.
J Infect Dis
; 209 Suppl 2: S46-8, 2014 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24872395
6.
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines.
J Infect Dis
; 207(5): 700-8, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225894
7.
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.
Lancet Infect Dis
; 23(10): 1175-1185, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390836
8.
Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate.
J Infect Dis
; 204(3): 442-50, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21742844
9.
Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.
Front Immunol
; 12: 640190, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33717194
10.
Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques.
J Virol
; 83(20): 10384-94, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19656873
11.
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1.
mSphere
; 5(1)2020 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969476
12.
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study.
Am J Trop Med Hyg
; 102(5): 951-954, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124728
13.
Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study.
Am J Trop Med Hyg
; 103(1): 132-141, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342848
14.
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.
Lancet Infect Dis
; 20(9): 1061-1070, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618279
15.
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
Nat Med
; 26(2): 228-235, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015557
16.
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.
Hum Vaccin
; 5(1): 33-40, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18670195
17.
Immunological Assays used to Support Efficacy of Zika Virus Vaccines.
Trop Med Infect Dis
; 4(3)2019 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31261617
18.
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions.
Hum Vaccin Immunother
; 15(9): 2090-2105, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30829100
19.
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.
Am J Trop Med Hyg
; 78(3): 426-33, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18337339
20.
Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico.
Am J Trop Med Hyg
; 98(5): 1435-1443, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512481